Chen YC - Search Results

1

STK31 maintains the undifferentiated state of colon cancer cells.

Fok KL, Chung CM, Yi SQ, Jiang X, Sun X, Chen H, Chen YC, Kung HF, Tao Q, Diao R, Chan H, Zhang XH, Chung YW, Cai Z, Chang Chan H. Fok KL, et al. Among authors: chen h, chen yc. Carcinogenesis. 2012 Nov;33(11):2044-53. doi: 10.1093/carcin/bgs246. Epub 2012 Jul 24. Carcinogenesis. 2012. PMID: 22828137

2

Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.

Ng SS, Cheung YT, An XM, Chen YC, Li M, Li GH, Cheung W, Sze J, Lai L, Peng Y, Xia HH, Wong BC, Leung SY, Xie D, He ML, Kung HF, Lin MC. Ng SS, et al. Among authors: chen yc. J Natl Cancer Inst. 2007 Jun 20;99(12):936-48. doi: 10.1093/jnci/djm011. Epub 2007 Jun 12. J Natl Cancer Inst. 2007. PMID: 17565152

3

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J, Hui CK, Lau GK, He ML, Sung J, Kung HF. Chen Y, et al. Hepatology. 2007 Jul;46(1):200-8. doi: 10.1002/hep.21668. Hepatology. 2007. PMID: 17596871

4

Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma.

Chen Y, Lin MC, Wang H, Chan CY, Jiang L, Ngai SM, Yu J, He ML, Shaw PC, Yew DT, Sung JJ, Kung HF. Chen Y, et al. Proteomics. 2007 Sep;7(17):3097-104. doi: 10.1002/pmic.200700019. Proteomics. 2007. PMID: 17676662

5

Inhibition of HBV gene expression and replication by stably expressed interferon-alpha1 via adeno-associated viral vectors.

Li Z, Yao H, Ma Y, Dong Q, Chen Y, Peng Y, Zheng BJ, Huang JD, Chan CY, Lin MC, Sung JJ, Yuen KY, Kung HF, He ML. Li Z, et al. J Gene Med. 2008 Jun;10(6):619-27. doi: 10.1002/jgm.1174. J Gene Med. 2008. PMID: 18383553 Free PMC article.

6

Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia.

Chen Y, Cheung YT, Kong LD, Ng TB, Qiao C, Mo SF, Xu HX, Kung HF. Chen Y, et al. Life Sci. 2008 May 23;82(21-22):1117-21. doi: 10.1016/j.lfs.2008.03.014. Epub 2008 Apr 1. Life Sci. 2008. PMID: 18445497

7

A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.

Dong Q, Chan HL, Liu Z, Chan DP, Zhang B, Chen Y, Kung HF, Sung JJ, He ML. Dong Q, et al. Biochem Biophys Res Commun. 2008 Oct 3;374(4):773-6. doi: 10.1016/j.bbrc.2008.07.115. Epub 2008 Aug 8. Biochem Biophys Res Commun. 2008. PMID: 18675784

8

Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells.

Jiang L, Chen Y, Chan CY, Wang X, Lin L, He ML, Lin MC, Yew DT, Sung JJ, Li JC, Kung HF. Jiang L, et al. Cancer Lett. 2009 Feb 8;274(1):101-8. doi: 10.1016/j.canlet.2008.09.017. Epub 2008 Oct 18. Cancer Lett. 2009. PMID: 18930345

9

Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma.

Wang X, Chen Y, Han QB, Chan CY, Wang H, Liu Z, Cheng CH, Yew DT, Lin MC, He ML, Xu HX, Sung JJ, Kung HF. Wang X, et al. Proteomics. 2009 Jan;9(2):242-53. doi: 10.1002/pmic.200800155. Proteomics. 2009. PMID: 19086098

10

Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells.

Zhang B, Bai YX, Ma HH, Feng F, Jin R, Wang ZL, Lin J, Sun SP, Yang P, Wang XX, Huang PT, Huang CF, Peng Y, Chen YC, Kung HF, Huang JJ. Zhang B, et al. Among authors: chen yc. Cancer Res. 2009 Jan 1;69(1):75-83. doi: 10.1158/0008-5472.CAN-08-1393. Cancer Res. 2009. PMID: 19117989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,023 results

Search Page

Filters